ARCHIVES

Duke’s Victor Dzau Named President of The Institute of Medicine

This article is from The Cancer Letter archive.

Vol. 40 No. 08 | February 21, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994